European Patent Office declares CureVac mRNA patent valid
The European Patent Office declared a patent owned by CureVac valid, after a challenge from drugmaker BioNTech, the company said on Thursday. U.S.-listed shares of Germany-based CureVac rose 11.8% in ...
CureVac stock rises on positive patent ruling against BioNTech
Shares of CureVac (NASDAQ: CVAC) climbed 11% following a favorable patent validity decision in its legal proceedings against BioNTech (NASDAQ: NASDAQ: BNTX). The ...
PharmiWeb9h
CureVac Receives Positive Validity Decision from European Patent Office in Litigation Against BioNTech SE
CET/CESTThe issuer is solely responsible for the content of this announcement.CureVac Receives Positive Validity Decision from European Patent Office in Litigation Against BioNTech SE European Patent ...
Trump administration cancels $12 billion in funding to state health departments
The U.S. Department of Health and Human Services has reportedly cancelled about $12 billion in federal grants to states ...